Home
/
ICU MEDICAL INC/DE
/
Financials
/
Quarterly
ICU MEDICAL INC/DE — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ICU MEDICAL INC/DE filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$536.99M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$548.87M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$604.70M
May 8, 2025
Q3
2025
Sep 30, 2024
$589.13M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$596.46M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$566.66M
May 8, 2025
Q3
2024
Sep 30, 2023
$553.31M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$549.31M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$568.65M
May 7, 2024
Q3
2023
Sep 30, 2022
$597.86M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$561.00M
Aug 7, 2023
Q1
2023
Mar 31, 2022
$543.12M
May 9, 2023
Q3
2022
Sep 30, 2021
$336.06M
Nov 7, 2022
Q2
2022
Jun 30, 2021
$321.68M
Aug 9, 2022
Q1
2021
Jun 30, 2021
$321.68M
Aug 4, 2021
Q1
2022
Mar 31, 2021
$318.05M
May 9, 2022
Q3
2021
Sep 30, 2020
$318.57M
Nov 5, 2021
Q2
2020
Jun 30, 2020
$303.38M
Aug 10, 2020
Q1
2021
Jun 30, 2020
$303.38M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$328.61M
May 7, 2021
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$536.99M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$548.87M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$604.70M
May 8, 2025
Q3
2025
Sep 30, 2024
$589.13M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$596.46M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$566.66M
May 8, 2025
Q3
2024
Sep 30, 2023
$553.31M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$549.31M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$568.65M
May 7, 2024
Q3
2023
Sep 30, 2022
$597.86M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$561.00M
Aug 7, 2023
Q1
2023
Mar 31, 2022
$543.12M
May 9, 2023
Q3
2022
Sep 30, 2021
$336.06M
Nov 7, 2022
Q1
2021
Jun 30, 2021
$321.68M
Aug 4, 2021
Q2
2022
Jun 30, 2021
$321.68M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$318.05M
May 9, 2022
Q3
2021
Sep 30, 2020
$318.57M
Nov 5, 2021
Q2
2020
Jun 30, 2020
$303.38M
Aug 10, 2020
Q1
2021
Jun 30, 2020
$303.38M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$328.61M
May 7, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.40M)
Nov 6, 2025
Q3
2025
Jun 30, 2025
$35.34M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$35.34M
Aug 7, 2025
Q3
2025
Mar 31, 2025
($15.48M)
Nov 6, 2025
Q1
2025
Mar 31, 2025
($15.48M)
May 8, 2025
Q2
2025
Mar 31, 2025
($15.48M)
Aug 7, 2025
Q3
2025
Sep 30, 2024
($32.98M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($21.41M)
Aug 7, 2025
Q3
2025
Jun 30, 2024
($21.41M)
Nov 6, 2025
Q3
2025
Mar 31, 2024
($39.47M)
Nov 6, 2025
Q2
2025
Mar 31, 2024
($39.47M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($39.47M)
May 8, 2025
Q1
2024
Sep 30, 2023
($39.47M)
May 7, 2024
Q3
2024
Sep 30, 2023
$7.24M
Nov 12, 2024
Q3
2024
Jun 30, 2023
($9.93M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($9.93M)
Aug 7, 2024
Q2
2024
Mar 31, 2023
($9.81M)
Aug 7, 2024
Q3
2024
Mar 31, 2023
($9.81M)
Nov 12, 2024
Q1
2023
Mar 31, 2023
($9.81M)
May 9, 2023
Q1
2024
Sep 30, 2022
($9.81M)
May 7, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$13.72M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$10.59M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$12.89M
May 8, 2025
Q3
2025
Sep 30, 2024
$8.24M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$7.69M
Aug 7, 2025
Q1
2025
Mar 31, 2024
($10.66M)
May 8, 2025
Q3
2024
Sep 30, 2023
$22.85M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$2.76M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$9.40M
May 7, 2024
Q3
2023
Sep 30, 2022
($467.0K)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($48.0K)
Aug 7, 2023
Q1
2023
Mar 31, 2022
($42.16M)
May 9, 2023
Q3
2022
Sep 30, 2021
$38.38M
Nov 7, 2022
Q1
2021
Jun 30, 2021
$34.47M
Aug 4, 2021
Q2
2022
Jun 30, 2021
$34.47M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$26.57M
May 9, 2022
Q3
2021
Sep 30, 2020
$25.53M
Nov 5, 2021
Q2
2020
Jun 30, 2020
$19.56M
Aug 10, 2020
Q1
2021
Jun 30, 2020
$19.56M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$26.06M
May 7, 2021